iRhom2 in the pathogenesis of oral squamous cell carcinoma

Agwae, Matthew E, Shaw, Richard J ORCID: 0000-0002-5157-4042, Triantafyllou, Asterios, Greaney, Frances ST, Ben Salah, Khaled and Risk, Janet M ORCID: 0000-0002-8770-7783
(2020) iRhom2 in the pathogenesis of oral squamous cell carcinoma. MOLECULAR BIOLOGY REPORTS, 47 (5). pp. 3987-3992.

[img] Text
Agwae et al iRhom2 in OSCC accepted version.pdf - Author Accepted Manuscript

Download (394kB) | Preview


iRhom2 is an inactive rhomboid protease involved in diverse signalling events. It has been implicated in the pathogenesis of a number of cancer types, including oesophageal and ovarian cancer, while its closely associated family member, iRhom1, is implicated in head and neck cancer. However, a role for iRhom2 in head and neck cancer has not been investigated. Immunoblotting for iRhom2 in 54 oral squamous cell carcinoma (OSCC) and 24 paired normal tissues demonstrated higher levels of iRhom2 protein in tumour compared with normal samples (P < 0.05). iRhom2 over-expression correlated with poor patient survival (P < 0.0005) but with no other clinicopathological variable. Increased cell migration was observed in stably over-expressing iRhom2 clones of OSCC cell lines in the absence of increased cell proliferation, but not in the normal oral keratinocyte cell line, NOK-hTERT, and this was abrogated by knock-down of iRhom2. iRhom2 protein expression is increased in a proportion of OSCC and this up-regulation is associated with faster cell migration and decreased patient survival. These data implicate iRhom2-controlled signalling events in the pathogenesis of this cancer.

Item Type: Article
Uncontrolled Keywords: iRhom2, Oral squamous cell carcinoma, Head and neck squamous cell carcinoma, Cell migration
Depositing User: Symplectic Admin
Date Deposited: 24 Mar 2020 11:36
Last Modified: 18 Jan 2023 23:57
DOI: 10.1007/s11033-020-05381-y
Related URLs: